These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21834951)

  • 1. FISH as an effective diagnostic tool for the management of challenging melanocytic lesions.
    Moore MW; Gasparini R
    Diagn Pathol; 2011 Aug; 6():76. PubMed ID: 21834951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
    Xavier-Junior JCC; Ocanha-Xavier JP
    Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic reassessment of melanoma and other melanocytic skin lesions excised in 2009 and 2018-2019.
    Gjersvik P; Veierød MB; Thompson A; Grzyb K; Liland KH; Vazov N; Roscher I; Bassarova AV
    Tidsskr Nor Laegeforen; 2022 Oct; 142(15):. PubMed ID: 36286556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
    Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
    J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
    Gammon B; Gerami P
    Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
    Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
    Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms?
    Zembowicz A; Scolyer RA
    Arch Pathol Lab Med; 2011 Mar; 135(3):300-6. PubMed ID: 21366452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
    March J; Hand M; Truong A; Grossman D
    J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
    Senetta R; Paglierani M; Massi D
    Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
    Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
    Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patients.
    Takai S; Arai E; Shojiguchi N; Nakamura Y; Momose S; Fukuda T; Ishizawa K; Ogata D; Tsunemi Y; Nakamura K; Tsuchida T
    J Dermatol; 2023 May; 50(5):637-645. PubMed ID: 36539950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FISH analysis for diagnostic evaluation of challenging melanocytic lesions.
    Zimmermann AK; Hirschmann A; Pfeiffer D; Paredes BE; Diebold J
    Histol Histopathol; 2010 Sep; 25(9):1139-47. PubMed ID: 20607656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary melanoma and dysplastic nevus syndrome.
    Ponz de Leon M
    Recent Results Cancer Res; 1994; 136():94-109. PubMed ID: 7863111
    [No Abstract]   [Full Text] [Related]  

  • 16. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
    Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
    Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostics for ambiguous melanocytic tumors.
    Shahbain H; Cooper C; Gerami P
    Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
    Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
    Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
    Zembowicz A; Yang SE; Kafanas A; Lyle SR
    Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study.
    Mesbah Ardakani N; Singh S; Thomas C; Van Vliet C; Harvey NT; Calonje JE; Wood BA
    Am J Dermatopathol; 2021 Mar; 43(3):182-190. PubMed ID: 32649342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.